FDA orders retesting for MDS lab clients (The Globe and Mail)
The U.S. Food and Drug Administration has told a number of pharmaceutical companies to confirm or repeat studies done for them by a unit of MDS Inc. because of concerns about their accuracy.

GrapeCity Brings Easy-to-Use, FDA-Compliant Regulatory Solutions to MS BioIT Alliance (Business Wire via Yahoo! Finance)
KIRKLAND, Wash.----GrapeCity today announced that it is joining the Microsoft-sponsored BioIT Alliance, which is dedicated to leveraging information technology to speed the introduction of new, personalized forms of medicine.